Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review

Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review

Primary Central Nervous System Lymphoma (PCNSL) is a rare variant of Non-Hodgkin Lymphoma (NHL) representing 1–2% of all NHL cases. PCNSL is defined as a lymphoma that occurs in the brain, spinal cord, leptomeninges, or eyes. Efforts to treat PCNSL by traditional chemotherapy and radiotherapy have g...

Full description

Bibliographic Details
Main Authors: Gaurav Nepal, Mahika Khurana, Domenica Herrera Bucheli, Siddhartha Bhandari, Utsav Joshi, Riwaj Bhagat, Jessica Holly Rehrig, Prasun Pudasainee, Yow Ka Shing, Juan Fernando Ortiz, Rajeev Ojha, Bikram Prasad Gajurel, Jonathan Quinonez, Samir Ruxmohan, Trevine Albert, Steven Licata, Joel Stien
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Neurology International
Subjects:
ibrutinib
BTK
Bruton tyrosine kinase inhibitor
PCNSL
primary central nervous system lymphoma
lymphoma
Online Access:https://www.mdpi.com/2035-8377/14/1/9

Internet

https://www.mdpi.com/2035-8377/14/1/9

Similar Items